$70 trillion-backed FAIRR investor network finds meat and dairy industry failing to manage its biodiversity impacts, undermining targets of a new global deal for nature and exposing companies to increased regulatory, legal and reputational risks New re
A randomized, triple-blind, placebo-controlled clinical trial involving supplementation with a bioflavonoid ingredient UP446 provides evidence for a robust, healthy immune response in healthy adults following influenza vaccination. VANCOUVER, British Col
CEPI and VBI expand scope of partnership to target multiple coronavirus threats Vaccine platform presents multiple antigens, mimicking natural form of the virus OSLO, Norway & CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Coalition for Epidemic Preparedness
- New findings underscore potential of CYB003 as a novel psychedelic-based therapeutic for the treatment of depression - TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American: CYBN) (Cybin or the Company), a biopharmaceutical company focused on
The Company to host an earnings conference call via webcast VICTORIA, British Columbia--(BUSINESS WIRE)--$IPA #AI--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an advanced biotherapeutic research and technology comp
VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced today that it has elected to transfer its stock exchange listing from the New York
Centered on biometric, fingerprint-based authentication to prevent identity fraud, the system includes numerous other functions to improve the customer experience. TORINO, Italy & DAYTON, Ohio--(BUSINESS WIRE)--Panini S.p.A., a global payments technology
New Klick Applied Sciences research presented at leading AI conference NEW YORK & TORONTO--(BUSINESS WIRE)--#AI--Scientists at Klick Applied Sciences have discovered a way to transform a continuous glucose monitor (CGM) into a powerful diabetes screening
TORONTO--(BUSINESS WIRE)--Everest Clinical Research (“Everest”), a leading full-service contract research organization (“CRO”) with deep expertise in biostatistics and statistical programming, today announced it has acquired Brightech Internationa
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan & LONDON--(BUSINESS WIRE)--Gensource Potash Corporation (“Gensource” or the “Company”) (AIM/TSXV: GSP), a fertilizer development company
“People’s mindsets are shifting. They care about the future of the planet, they want sustainable food options and they’re willing to pay for it, providing it tastes great,” says Leggett.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.